vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Turning Point Brands, Inc. (TPB). Click either name above to swap in a different company.

Turning Point Brands, Inc. is the larger business by last-quarter revenue ($121.0M vs $89.1M, roughly 1.4× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs 6.8%, a 0.7% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 29.2%). Turning Point Brands, Inc. produced more free cash flow last quarter ($21.5M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 20.7%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Turning Point Australia (TPAUS) is a conservative lobby group based in Australia, affiliated with Turning Point USA but independent of it. Founded by Joel Jammal and first registered in 2023, the group has become active in trying to influence the outcome of the 2026 South Australian state election in March 2026.

HROW vs TPB — Head-to-Head

Bigger by revenue
TPB
TPB
1.4× larger
TPB
$121.0M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+4.1% gap
HROW
33.3%
29.2%
TPB
Higher net margin
HROW
HROW
0.7% more per $
HROW
7.4%
6.8%
TPB
More free cash flow
TPB
TPB
$13.4M more FCF
TPB
$21.5M
$8.1M
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
20.7%
TPB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
TPB
TPB
Revenue
$89.1M
$121.0M
Net Profit
$6.6M
$8.2M
Gross Margin
79.3%
55.9%
Operating Margin
17.5%
16.5%
Net Margin
7.4%
6.8%
Revenue YoY
33.3%
29.2%
Net Profit YoY
-2.2%
239.8%
EPS (diluted)
$0.20
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
TPB
TPB
Q4 25
$89.1M
$121.0M
Q3 25
$71.6M
$119.0M
Q2 25
$63.7M
$116.6M
Q1 25
$47.8M
$106.4M
Q4 24
$66.8M
$93.7M
Q3 24
$49.3M
$90.7M
Q2 24
$48.9M
$93.2M
Q1 24
$34.6M
$83.1M
Net Profit
HROW
HROW
TPB
TPB
Q4 25
$6.6M
$8.2M
Q3 25
$1.0M
$21.1M
Q2 25
$5.0M
$14.5M
Q1 25
$-17.8M
$14.4M
Q4 24
$6.8M
$2.4M
Q3 24
$-4.2M
$12.4M
Q2 24
$-6.5M
$13.0M
Q1 24
$-13.6M
$12.0M
Gross Margin
HROW
HROW
TPB
TPB
Q4 25
79.3%
55.9%
Q3 25
75.3%
59.2%
Q2 25
74.5%
57.1%
Q1 25
67.5%
56.0%
Q4 24
78.8%
56.0%
Q3 24
75.6%
55.6%
Q2 24
74.4%
54.1%
Q1 24
69.5%
58.2%
Operating Margin
HROW
HROW
TPB
TPB
Q4 25
17.5%
16.5%
Q3 25
20.6%
21.8%
Q2 25
17.9%
22.6%
Q1 25
-23.5%
21.8%
Q4 24
19.3%
19.1%
Q3 24
2.7%
22.9%
Q2 24
3.1%
24.5%
Q1 24
-20.0%
23.2%
Net Margin
HROW
HROW
TPB
TPB
Q4 25
7.4%
6.8%
Q3 25
1.4%
17.7%
Q2 25
7.8%
12.4%
Q1 25
-37.2%
13.5%
Q4 24
10.1%
2.6%
Q3 24
-8.6%
13.6%
Q2 24
-13.2%
14.0%
Q1 24
-39.2%
14.5%
EPS (diluted)
HROW
HROW
TPB
TPB
Q4 25
$0.20
$0.40
Q3 25
$0.03
$1.13
Q2 25
$0.13
$0.79
Q1 25
$-0.50
$0.79
Q4 24
$0.19
$0.15
Q3 24
$-0.12
$0.68
Q2 24
$-0.18
$0.68
Q1 24
$-0.38
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
TPB
TPB
Cash + ST InvestmentsLiquidity on hand
$72.9M
$222.8M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$372.0M
Total Assets
$399.5M
$763.8M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
TPB
TPB
Q4 25
$72.9M
$222.8M
Q3 25
$74.3M
$201.2M
Q2 25
$53.0M
$109.9M
Q1 25
$66.7M
$99.6M
Q4 24
$47.2M
$48.9M
Q3 24
$72.6M
$33.6M
Q2 24
$71.0M
$142.2M
Q1 24
$76.0M
$130.9M
Total Debt
HROW
HROW
TPB
TPB
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
TPB
TPB
Q4 25
$52.4M
$372.0M
Q3 25
$47.0M
$358.2M
Q2 25
$49.7M
$224.8M
Q1 25
$56.5M
$203.4M
Q4 24
$69.7M
$190.4M
Q3 24
$58.0M
$185.7M
Q2 24
$58.5M
$172.8M
Q1 24
$60.6M
$160.0M
Total Assets
HROW
HROW
TPB
TPB
Q4 25
$399.5M
$763.8M
Q3 25
$363.1M
$742.8M
Q2 25
$345.0M
$595.8M
Q1 25
$364.2M
$564.6M
Q4 24
$389.0M
$493.4M
Q3 24
$351.5M
$488.0M
Q2 24
$306.6M
$591.6M
Q1 24
$295.5M
$586.3M
Debt / Equity
HROW
HROW
TPB
TPB
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
TPB
TPB
Operating Cash FlowLast quarter
$8.4M
$24.9M
Free Cash FlowOCF − Capex
$8.1M
$21.5M
FCF MarginFCF / Revenue
9.1%
17.8%
Capex IntensityCapex / Revenue
0.4%
2.8%
Cash ConversionOCF / Net Profit
1.27×
3.03×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$43.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
TPB
TPB
Q4 25
$8.4M
$24.9M
Q3 25
$16.6M
$3.3M
Q2 25
$-803.0K
$11.8M
Q1 25
$19.7M
$17.4M
Q4 24
$-17.8M
$17.7M
Q3 24
$3.0M
$13.2M
Q2 24
$-2.7M
$13.4M
Q1 24
$-4.6M
$22.6M
Free Cash Flow
HROW
HROW
TPB
TPB
Q4 25
$8.1M
$21.5M
Q3 25
$16.4M
$-721.0K
Q2 25
$-969.0K
$7.8M
Q1 25
$19.5M
$15.2M
Q4 24
$-18.3M
$16.6M
Q3 24
$2.3M
$12.6M
Q2 24
$-3.1M
$10.9M
Q1 24
$-4.7M
$22.3M
FCF Margin
HROW
HROW
TPB
TPB
Q4 25
9.1%
17.8%
Q3 25
22.9%
-0.6%
Q2 25
-1.5%
6.7%
Q1 25
40.8%
14.3%
Q4 24
-27.4%
17.8%
Q3 24
4.8%
13.9%
Q2 24
-6.3%
11.7%
Q1 24
-13.6%
26.8%
Capex Intensity
HROW
HROW
TPB
TPB
Q4 25
0.4%
2.8%
Q3 25
0.3%
3.4%
Q2 25
0.3%
3.4%
Q1 25
0.4%
2.1%
Q4 24
0.8%
1.2%
Q3 24
1.2%
0.7%
Q2 24
0.7%
2.7%
Q1 24
0.3%
0.4%
Cash Conversion
HROW
HROW
TPB
TPB
Q4 25
1.27×
3.03×
Q3 25
16.26×
0.16×
Q2 25
-0.16×
0.82×
Q1 25
1.21×
Q4 24
-2.62×
7.34×
Q3 24
1.07×
Q2 24
1.03×
Q1 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

TPB
TPB

US$111.5M92%
Non Us$9.6M8%

Related Comparisons